We serve Chemical Name:Ethyl 5-hydroxy-1H-indole-3-carboxylate CAS:24370-69-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Ethyl 5-hydroxy-1H-indole-3-carboxylate
CAS.NO:24370-69-2
Synonyms:5-hydroxy-indole-3-carboxylic acid ethyl ester;5-Hydroxy-1H-indole-3-carboxylic acid,ethyl ester
Molecular Formula:C11H11NO3
Molecular Weight:205.21000
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:62.32000
Exact Mass:205.07400
LogP:2.05020
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-hydroxy-indole-3-carboxylic acid ethyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Hydroxy-1H-indole-3-carboxylic acid,ethyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Hydroxy-1H-indole-3-carboxylic acid,ethyl ester Use and application,5-hydroxy-indole-3-carboxylic acid ethyl ester technical grade,usp/ep/jp grade.
Related News: The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses. Ethyl 5-hydroxy-1H-indole-3-carboxylate manufacturer Using a proprietary chemistry platform, Onconova has created a pipeline of targeted agents designed to work against specific cellular pathways that are important in cancer cells. Ethyl 5-hydroxy-1H-indole-3-carboxylate supplier Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added ��The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova. Ethyl 5-hydroxy-1H-indole-3-carboxylate vendor Using a proprietary chemistry platform, Onconova has created a pipeline of targeted agents designed to work against specific cellular pathways that are important in cancer cells. Ethyl 5-hydroxy-1H-indole-3-carboxylate factory Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added ��The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.
